15 July, 2024
Quarterly Activities & Appendix 4C June 2024
● Record cash receipts of $3.23m in Q4 FY24, up 118% vs PCP
● Biome reports record quarterly sales revenue $3.8m, up 88% vs PCP
● Accounts receivable increase from $2.44m to $2.99m over the quarter
● Biome maintains gross margin above 60% for Q4 FY24
● As at June 30th, the company has a cash balance of $2.86m
● Biome records a third consecutive quarter of positive cash flow for Q4 FY24
● Biome records a second consecutive quarter of positive EBITDA for Q4 FY24
● Same-store pharmacy sales for Q4 up 78% vs PCP
What a stellar Quarterly
Ann: Quarterly Activities & Cashflow Report, page-2
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
0.010(2.08%) |
Mkt cap ! $105.5M | |||
| Open | High | Low | Value | Volume |
| 48.5¢ | 52.0¢ | 47.0¢ | $491.2K | 988.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13347 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| BIO (ASX) Chart |